Influence of Feeding and Analytical Method on the Bioequivalence of a Racemic Drug undergoing Enantioselective Enterohepatic Recycling

Journal of Pharmaceutical Sciences

Volumn 93, Issue 3, 2004, Pages 590-600

  Priymenko, Nathalie M H ^a   Koritz, Gary D ^b   Ferre, Jean Pierre ^a   Laroute, Valerie M F ^a   Toutain, Pierre Louis ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Bioequivalence; Carprofen; Dog; Enantioselectivity; Enterohepatic recycling

Indexed keywords

CARPROFEN;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BILE FLOW; BIOEQUIVALENCE; CONCENTRATION RESPONSE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSSING OVER; DOG; DRUG FORMULATION; DRUG HALF LIFE; DUODENUM; ENANTIOSELECTIVITY; ENTEROHEPATIC CIRCULATION; FEEDING; FEEDING BEHAVIOR; INTERMETHOD COMPARISON; MALE; MATHEMATICAL ANALYSIS; NONHUMAN; RACEMIC MIXTURE; STATISTICAL ANALYSIS;

EID: 1542724952     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10581     Document Type: Article

References (26)

1. Ricketts PA, Lundy KM, Seibel SB. 1998. Evaluation of selective inhibition of canine cyclooxygenase 1 and 2 by carprofen and other nonsteroidal anti-inflammatory drugs. Am J Vet Res 59:1441-1446.
2. Karim A. 1996. Enantioselective assays in comparative bioavailability studies of racemic drug formulations: Nice to know or need to know? J Clin Pharmacol 36:490-499.
3. Mehvar R, Jamali F. 1997. Bioequivalence of chiral drugs: Stereospecific versus non-stereospecific methods. Clin Pharmacokinet 33:122-141.
4. Delatour P, Benoit E, Bourdin M, Gobron M, Moysan F. 1993. Enantiosélectivité comparée de la disposition de deux anti-inflammatoires non stéroidiens, le kétoprofène et le carprofène, chez l'homme et l'animal. Bull Acad Natl Med 177:515-527.
5. McKellar QA, Delatour P, Lees P. 1994. Stereo-specific pharmacodynamics and pharmacokinetics of carprofen in the dog. J Vet Pharmacol Ther 17:447-454.
6. Priymenko N, Garnier F, Ferre J-P, Delatour P, Toutain P-L. 1998. Enantioselectivity of the enterohepatic recycling of carprofen in the dog. Drug Metab Dispos 26:170-176.
7. Itoh Z, Takahashi I. 1981. Periodic contractions of the canine gallbladder during the interdigestive state. Am J Physiol 240:G183-G189.
8. Traynor OJ, Dozois RR, DiMagno EP. 1984. Canine digestive and postprandial gallbladder motility and emptying. Am J Physiol 246:G426-G432.
9. Jonderko K, Ferre J-P, Bueno L. 1992. Real-time ultrasonography as a noninvasive tool for the examination of canine gallbladder emptying: A validation study. J Pharmacol Methods 27:107-111.
10. Foster RT, Jamali F. 1987. High-performance liquid chromatographic assay of ketoprofen enantiomers in plasma and urine. J Chromatogr 416:388-393.
11. Yamaoka K, Nakagawa T, Uno T. 1978. Statistical moments in pharmacokinetics. J Pharmacokinet Biopharm 6:547-558.
12. Grizzle JE. 1965. The two-period change-over design and its use in clinical trials. Biometrics 21:467-480.
13. Schuirmann DJ. 1987. A comparison of two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm 15:657-680.
14. Hauschke D, Steinijans VW, Diletti E, Schall R, Luus HG, Blume H. 1994. Presentation of the intrasubject coefficient of variation for sample size planning in bioequivalence studies. Int J Clin Pharmacol Ther 32:376-378.
15. Midha KK, Ormsby ED, Hubbard JW, McKay G, Hawes EM, Gavalas L, McGilveray IJ. 1993. Logarithmic transformation in bioequivalence: Application with two formulations of perphenazine. J Pharm Sci 82:138-144.
16. Diletti E, Hauschke D, Steinijans VW. 1991. Sample size determination for bioequivalence assessment by means of confidence intervals. Int J Clin Pharmacol Ther Toxicol 29:1-8.
17. Diletti E, Hauschke D, Steinijans VW. 1992. Sample size determination: Extended tables for the multiplicative model and bioequivalence ranges of 0.9 to 1.11 and 0.7 to 1.43. Int J Clin Pharmacol Ther Toxicol 30:S59-S62.
18. De Wever I, Eeckhout C, Vantrappen G, Hellemans J. 1978. Disruptive effect of test meals on interdigestive motor complex in dogs. Am J Physiol 235: E661-E669.
19. Qvist N, Oster-Jorgensen E, Rasmussen L, Hovendal C, Pedersen SA. 1989. Postprandial gallbladder filling: Relation to gastrointestinal motility. Scand J Gastroenterol 24:969-974.
20. Hooper WD, Dickinson RG, Gal J. 1992. Enantio-selective versus non-enantioselective assays in comparative bioavailability studies with racemic drugs. Biopharm Drug Dispos 13:383-385.
21. Food and Drug Administration, US Department of Health and Human Services, Center for Drug Evaluation and Research: Guidance for Industry, Bioavailability and Bioequivalence Studies for Orally Administered Drug Products, General Considerations. http://www.fda.gov/cder/guidance/index.htm. Accessed January 2003.
22. Chang CT, Wong RL. 1997. Assessment of intrasubject variability of pharmacokinetic parameters in clinical studies. Drug Inf J 31:1203-1213.
23. Chow SC, Tse SK. 1990. A related problem in bioavailability/bioequivalence studies. Estimation of the intrasubject variability with a common CV. Biomed J 5:597-607.
24. Midha KK, Rawson MJ, Hubbard JW. 1998. Bioequivalence: Switchability and scaling. Eur J Pharm Sci 6:87-91.
25. Benoit E, Soraci A, Delatour P. 1993. An in vivo-in vitro correlation in the chiral inversion of carprofen, ketoprofen, and fenoprofen in dogs. 5th European ISSX Meeting Tours (France), p 42.
26. Midha KK, Rawson MJ, Hubbard JW. 1997. Bioequivalence: Issues and options. J Pharmacokinet Biopharm 25:743-752.